Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice

Neuropharmacology

Volumn 67, Issue , 2013, Pages 503-510

  Balu, Darrick T ^a   Turner, Jill R ^a   Brookshire, Bethany R ^a   Hill Smith, Tiffany E ^a   Blendy, Julie A ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C57BL 6J; Citalopram; Desipramine; Hippocampus; In vivo microdialysis; MRL MpJ; Norepinephrine; Serotonin; Tail suspension test

Indexed keywords

DOPAMINE; MONOAMINE; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; C57BL 6 MOUSE; CONTROLLED STUDY; EXTRACELLULAR SPACE; HYPOTHALAMUS; MALE; MICRODIALYSIS; MONOAMINE RELEASE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; SPECIES SPECIFICITY; TREATMENT OUTCOME;

EID: 84873396890     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.11.027     Document Type: Article

References (41)

1. D.T. Balu, G.E. Hodes, B.T. Anderson, and I. Lucki Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments Neuropsychopharmacology 34 2009 1764 1773
2. D.T. Balu, and I. Lucki Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology Neurosci. Biobehav Rev. 33 2009 232 252
3. N. Bel, and F. Artigas Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study Eur. J. Pharmacol. 229 1992 101 103
4. M. Brocco, A. Dekeyne, S. Veiga, S. Girardon, and M.J. Millan Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents Pharmacol. Biochem. Behav. 71 2002 667 680
5. L. Capuron, and A.H. Miller Immune system to brain signaling: neuropsychopharmacological implications Pharmacol. Ther. 130 2011 226 238
6. L.D. Clark, R.K. Clark, and E. Heber-Katz A new murine model for mammalian wound repair and regeneration Clin. Immunol. Immunopathol. 88 1998 35 45
7. T.I. Cremers, K. Rea, F.J. Bosker, H.V. Wikstrom, S. Hogg, A. Mork, and B.H. Westerink Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies Neuropsychopharmacology 32 2007 1550 1557
8. J.J. Crowley, J.A. Blendy, and I. Lucki Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test Psychopharmacology (Berl) 183 2005 257 264
9. J.J. Crowley, and I. Lucki Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics Curr. Pharm. Des. 11 2005 157 169
10. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci. Biobehav Rev. 29 2005 571 625
11. J.F. Cryan, O.F. O'Leary, S.H. Jin, J.C. Friedland, M. Ouyang, B.R. Hirsch, M.E. Page, A. Dalvi, S.A. Thomas, and I. Lucki Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors Proc. Natl. Acad. Sci. U. S. A. 101 2004 8186 8191
12. K.M. Dewar, T.A. Reader, L. Grondin, and L. Descarries [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region Synapse 9 1991 14 26
13. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol. Psychiatry 59 2006 1116 1127
14. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press Toronto
15. A. Frazer Antidepressants J. Clin. Psychiatry 58 Suppl. 6 1997 9 25
16. E.C. Gavioli, C.W. Vaughan, G. Marzola, R. Guerrini, V.A. Mitchell, S. Zucchini, T.C. De Lima, G.A. Rae, S. Salvadori, D. Regoli, and G. Calo Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice Naunyn Schmiedebergs Arch. Pharmacol. 369 2004 547 553
17. A. Gobert, J.M. Rivet, L. Cistarelli, C. Melon, and M.J. Millan Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats J. Neurochem. 69 1997 2616 2619
18. A. Gosain, S.B. Jones, R. Shankar, R.L. Gamelli, and L.A. DiPietro Norepinephrine modulates the inflammatory and proliferative phases of wound healing J. Trauma 60 2006 736 744
19. E. Heber-Katz, J. Leferovich, K. Bedelbaeva, D. Gourevitch, and L. Clark The scarless heart and the MRL mouse Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 2004 785 793
20. S. Hjorth, H.J. Bengtsson, A. Kullberg, D. Carlzon, H. Peilot, and S.B. Auerbach Serotonin autoreceptor function and antidepressant drug action J. Psychopharmacol. 14 2000 177 185
21. G.E. Hodes, T.E. Hill-Smith, R.F. Suckow, T.B. Cooper, and I. Lucki Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice J. Pharmacol. Exp. Ther. 332 2010 266 273
22. G. Imre, A. Salomons, M. Jongsma, D.S. Fokkema, J.A. Den Boer, and G.J. Ter Horst Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat Pharmacol. Biochem. Behav. 84 2006 392 399
23. D.A. Knobelman, R. Hen, J.A. Blendy, and I. Lucki Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse J. Pharmacol. Exp. Ther. 298 2001 1092 1100
24. D.A. Knobelman, R. Hen, and I. Lucki Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse J. Pharmacol. Exp. Ther. 298 2001 1083 1091
25. D.A. Knobelman, H.F. Kung, and I. Lucki Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors J. Pharmacol. Exp. Ther. 292 2000 1111 1117
26. D.S. Kreiss, and I. Lucki Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei J. Pharmacol. Exp. Ther. 269 1994 1268 1279
27. J.M. Leferovich, K. Bedelbaeva, S. Samulewicz, X.M. Zhang, D. Zwas, E.B. Lankford, and E. Heber-Katz Heart regeneration in adult MRL mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 9830 9835
28. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology (Berl) 155 2001 315 322
29. G. MacQueen, and T. Frodl The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol. Psychiatry 16 2011 252 264
30. I. Malagie, A.C. Trillat, M. Bourin, C. Jacquot, R. Hen, and A.M. Gardier 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex J. Neurochem. 76 2001 865 871
31. A. Malinin, B. Oshrine, and V. Serebruany Treatment with selective serotonin reuptake inhibitors for enhancing wound healing Med. Hypotheses 63 2004 103 109
32. A.J. Mayorga, and I. Lucki Limitations on the use of the C57BL/6 mouse in the tail suspension test Psychopharmacology (Berl) 155 2001 110 112
33. O.F. O'Leary, A.J. Bechtholt, J.J. Crowley, T.E. Hill, M.E. Page, and I. Lucki Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test Psychopharmacology (Berl) 192 2007 357 371
34. C. Sanchez, and J. Hyttel Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding Cell. Mol. Neurobiol. 19 1999 467 489
35. Y.I. Sheline, M. Sanghavi, M.A. Mintun, and M.H. Gado Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J. Neurosci. 19 1999 5034 5043
36. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
37. G. Tanda, E. Carboni, R. Frau, and G. Di Chiara Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) 115 1994 285 288
38. 3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding J. Pharmacol. Exp. Ther. 260 1992 427 436
39. S. Thuret, N. Toni, S. Aigner, G.W. Yeo, and F.H. Gage Hippocampus-dependent learning is associated with adult neurogenesis in MRL/MpJ mice Hippocampus 19 2009 658 669
40. V.A. Vaidya, K.C. Vadodaria, and S. Jha Neurotransmitter regulation of adult neurogenesis: putative therapeutic targets CNS Neurol. Disord. Drug Targets 6 2007 358 374
41. K. Wager-Smith, and A. Markou Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci. Biobehav. Rev. 35 2011 742 764